Abstract
Thirty-eight patients (⩾18 years) receiving marrow transplants from HLA-identical or one antigen- mismatched related donors were randomized to intraosseous (i.o.) + intravenous (i.v.) (n = 10), i.o. (n = 8) or i.v. (n = 20) infusions of bone marrow. There were no significant differences in patient characteristics. PMN/l more than 0.5 × 109 occurred on days 19 (median), 20 and 18.5 in the i.o. + i.v., i.o. and i.v. groups, respectively. We found a significant reduction in the number of days on total parenteral nutrition (P = 0.03) and a tendency to a reduction in the number of days on antibiotics (P = 0.06) in the i.o. compared to the i.v. group. Bacteraemia did not occur in the i.o. group, but was seen in 30% of the i.v. group (NS). The incidences of acute and chronic graft-versus-host disease, transplantation-related mortality, relapse and patient survival rates were similar in the three groups. Five patients examined with bone marrow scintigraphy showed the same distribution of granulocytes in the bone marrow directly after transplantation and 3 weeks after transplantation, whether the bone marrow was given by the i.o. or by the i.v. route. We conclude that allogeneic bone marrow transplantation can safely be performed by i.o. infusion, but haematopoietic recovery is not improved.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hägglund, H., Ringdén, O., Ågren, B. et al. Intraosseous compared to intravenous infusion of allogeneic bone marrow. Bone Marrow Transplant 21, 331–335 (1998). https://doi.org/10.1038/sj.bmt.1701116
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701116
Keywords
This article is cited by
-
Intrabone infusion for allogeneic umbilical cord blood transplantation in children
Bone Marrow Transplantation (2021)
-
A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin
Annals of Hematology (2021)
-
Twenty-year follow-up of a randomized trial comparing intraosseous and i.v. BM transplantation
Bone Marrow Transplantation (2014)
-
Superselective intra-arterial umbilical cord blood administration to BM in experimental animals
Bone Marrow Transplantation (2014)
-
Going straight to the point: intra-BM injection of hematopoietic progenitors
Bone Marrow Transplantation (2010)